Back to Top
Sarilumab Biosimilar - HRP Research Grade
Sarilumab Biosimilar - Research Grade: HRP
Unconjugated Product:Sarilumab Biosimilar - Research Grade
Conjugate:Horse Radish Peroxidase (HRP)
Target:IL-6R
Clone:n/a
Isotype:Human IgG1(E356D/M358L)-Kappa
Other Names:Receptor tyrosine-protein kinase erbB-2, MLN 19, HER2, HER2/neu
Host:CHO Cells
Species Reactivity:Human
Specificity:Detects human IL-6R.
Background:Sarilumab is a humanized Human IgG1(E356D/M358L)-Kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Sarilumab is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary).
Concentration:0.5 mg/ml
Formulation:This HRP-conjugated antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4, 1% BSA. (Warning: Use of sodium azide as a preservative will inhibit the enzyme activity of horseradish peroxidase).
Storage:This HRP conjugate is stable when stored at 2-8°C. Do not freeze.
Applications:Flow Cytometry, ELISA
Application Notes:Each investigator should determine their own optimal working dilution for specific applications.
Use: ichorbio's Sarilumab biosimilar is for research use only (RUO). Isotype Control:| Concentration | 5.49mg/ml |
|---|---|
| isotype | Human IgG1(E356D/M358L)-Kappa |
| Host | CHO Cells |
Write Your Own Review
Who Viewed This Also Viewed
